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Calpain is a Ca2+-activated, heterodimeric cysteine protease consisting of a large
catalytic subunit and a small regulatory subunit. Dysregulation of this enzyme
is involved in a range of pathological conditions such as cancer, Alzheimer’s
disease and rheumatoid arthritis, and thus calpain I is a drug target with
potential therapeutic applications. Difficulty in the production of this enzyme
has hindered structural and functional investigations in the past, although
heterodimeric calpain I can be generated by Escherichia coli expression in low
yield. Here, an unexpected structure discovered during crystallization trials of
heterodimeric calpain I (CAPN1C115S + CAPNS1GR) is reported. A novel
co-crystal structure of the PEF(S) domain from the dissociated regulatory small
subunit of calpain I and the RNA-binding chaperone Hfq, which was likely to be
overproduced as a stress response to the recombinant expression conditions, was
obtained, providing unexpected insight in the chaperone function of Hfq.
1. Introduction
Proteases are ubiquitous in cellular processes that respond to
a range of stimuli and signalling molecules. Calpains are a
family of calcium-activated cysteine proteases consisting of 15
known isoforms in the human body. They respond to intra-
cellular increases in Ca2+ by the specific and regulated cleav-
age of a variety of targets involved in signalling pathways such
as apoptosis (Wang et al., 2016), chemotaxis (Hallett & Dewitt,
2007) and cell motility (Santella et al., 1998; Miller et al., 2013).
The two most studied isoforms, calpain I and calpain II, are
heterodimeric proteins consisting of a large subunit (80 kDa)
and a regulatory subunit (CAPNS1; 30 kDa). The large
subunit contains the active site (the CysPc domain), a calcium-
binding penta-EF-hand domain [PEF(L)], a calpain-type -
sandwich domain (CBSW) and an N-terminal anchor -helix
(Ono et al., 2016). The regulatory subunit CAPNS1 (30 kDa)
comprises two domains: a glycine-rich domain (GR) and
another calcium-binding penta-EF-hand domain [PEF(S)]
(Adams et al., 2015). Calpain I and calpain II are activated in
vitro by calcium concentrations of 50 and 350 mM, respectively.
The large subunits of calpain I and calpain II share 62%
sequence identity, while the small subunits of the two proteins
are identical (Goll et al., 2003; Hitomi et al., 1998).
Calpain I and calpain II have been targeted to treat various
conditions including rheumatoid arthritis, ischemic cell death
and cancer (Miller et al., 2013; Bartus et al., 1995; Yamashima,
2004; Luo et al., 2015). The precise involvement of the indi-
vidual enzyme isoforms in these processes remains unclear.
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Structural insights from crystallographic data on the hetero-
dimeric calpain I complex could accelerate the development
of therapeutics. This has been hindered by a lack of available
material owing to low-yielding recombinant expression as well
as challenging protein properties such as subunit dissociation,
aggregation and autolysis (Hata et al., 2012; Pal et al., 2001). To
tackle such difficult-to-express proteins, Escherichia coli strain
C41 was developed, which is particularly well suited to the
expression of toxic and membrane proteins.
Here, we present our results on the expression, purification
and structure determination of human calpain I, which led to
an unusual structure of the PEF(S) domain from the regula-
tory subunit of calpain bound to the RNA chaperone Hfq.
2. Materials and methods
2.1. Protein purification
E. coli C41 (DE3) pLysS cells containing the CAPN1C115S
(80 kDa) and CAPNS1GR (20 kDa; CAPNS1 with a trun-
cated GR domain; Hata et al., 2013) genes were grown at 37C
in kanamycin- and ampicillin-selective TB(Enhanced) medium
until the OD600 reached 0.9. Subsequently, protein production
was induced with 1 mM IPTG. The protein was expressed
overnight at 20C and the cells were harvested by centrifu-
gation in a Sorvall RC6 Plus centrifuge (Thermo Fisher
Scientific, Massachusetts, USA) using an SLA-3000 rotor at
6080g for 20 min at 4C. The cells were resuspended in 20 mM
HEPES, 0.5 mM EGTA, 0.5 mM TCEP pH 7.6 (buffer A) and
lysed by sonication for 5 min (pulsed; 5 s on, 10 s off). The
lysate was clarified by centrifugation at 4C for 40 min at
30 310g in a Sorvall RC6 Plus centrifuge. The supernatant was
passed through a 0.2 mm syringe filter and applied onto an Ni–
NTA column. The unbound protein was washed out with 15
column volumes (CV) of buffer A and the target protein was
eluted with 10 CV buffer A supplemented with 250 mM
imidazole. The eluted fraction containing the target protein
was then applied onto a Mono Q HR 10/10 column (GE
Healthcare) pre-equilibrated with buffer A. The protein was
eluted with a linear gradient of 0–0.5 M NaCl in buffer A over
7 CV. The purity of the peak fractions was assessed by SDS–
PAGE (10%). The solution containing the protein complex
was concentrated to 10 mg ml1 using a 30 kDa molecular-
weight cutoff Vivaspin concentrator. Macromolecule-
production information is summarized in Table 1.
2.2. Crystallization
Crystals of PEF(S)–Hfq were grown at 20C in sitting-
drop vapour-diffusion plates containing equal volumes of
precipitant [0.1 M MMT (malic acid, MES and Tris in a 1:2:2
molar ratio), 25%(v/v) PEG 1500 pH 9.0] and the
CAPN1C115S–CAPNS1GR protein solution. Crystals were
observed after 2–3 weeks. The crystals were cryoprotected
with 10% ethylene glycol before being flash-cooled in liquid
nitrogen and stored until data collection. Crystallization
information is summarized in Table 2.
2.3. Data collection and refinement
The resulting crystals were cubic, belonging to space group
P213 (unit-cell parameters a = b = c = 147.61 A˚), and diffracted
to a higher resolution limit ranging from 2.9 to 2.3 A˚. The
structure was determined by molecular replacement using
Phaser (McCoy et al., 2007) and MOLREP (Vagin &
Teplyakov, 2010) as implemented within the CCP4i2 frame-
work (Potterton et al., 2018). PDB entry 1df0 (Hosfield et al.,
1999) was used as a starting model. Only domain VI, PEF(S),
could be placed by MR. All attempts to place the second
subunit led to stalled or increased R values during molecular
replacement and subsequent refinement. The partial model
was refined using alternating rounds of reciprocal refinement
with REFMAC5 (Murshudov et al., 1997, 2011) and real-space
refinement in Coot (Emsley et al., 2010). A polyalanine model
from short stretches of ideal -strand segments was built in the
remaining unexplained electron density, subsequently refined
and rebuilt to achieve a near-complete model. A combination
of partial sequence information based on interpreted side-
chain density, as well as fold comparison using the DALI
server (Holm & Sander, 1995), pointed to Hfq as the most
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Table 1
Macromolecule-production information.
The expression host and vectors used for PEF(S)–Hfq protein production.
Source organism Homo sapiens
DNA source CAPN1C115S (His6 tag)/CAPNS1GR
Expression vector pET24(+)/pACpET24
Expression host E. coli C41 (DE3) pLysS
Table 2
Crystallization.
Conditions used for PEF(S)–Hfq crystallization trials.
Method Vapour diffusion
Plate type Sitting drop
Temperature (K) 293
Protein concentration (mg ml1) 10
Buffer composition of protein
solution
20 mM HEPES, 0.5 mM EGTA, 0.5 mM
TCEP pH 7.6
Composition of reservoir solution 0.1 M MMT, 25% PEG 1500 pH 9.0
Volume and ratio of drop 200 nl, 1:1
Volume of reservoir (ml) 50
Table 3
Data collection and processing.
Data-collection and processing statistics for the PEF(S)–Hfq data set are
presented. Values in parentheses are for the outer shell.
Diffraction source I04, Diamond Light Source
Wavelength (A˚) 0.9795
Temperature (K) 100
Detector PILATUS3 6M, Dectris
Space group P213
a, b, c (A˚) 147.607, 147.607, 147.607
, ,  () 90.0, 90.0, 90.0
Resolution range (A˚) 2.32–66.02
Total No. of reflections 1029720 (75756)
No. of unique reflections 46565 (3416)
Completeness (%) 100.0 (100.0)
hI/(I)i 19.2 (3.0)
Rr.i.m. (%) 11.6 (114.1)
Overall B factor from Wilson plot (A˚2) 42.6
likely second domain in the obtained crystal structure. This
was confirmed by the successful model building and refine-
ment of the partial model with Buccaneer (Cowtan, 2006) and
REFMAC5 using the correct sequence as input. Further
rounds of graphical adjustment of the model using Coot, and
refinement with REFMAC5, led to the final model. Other data
analysis was completed with programs in the CCP4 package.
The electron-density map revealed that the asymmetric unit
contained four copies of the PEF(S) domain and four copies
of the Hfq chaperone protein, which were noncovalently
bound, and the structure was refined to Rwork and Rfree values
of 0.201 and 0.247, respectively. Data-collection and proces-
sing statistics are summarized in Table 3 and refinement
statistics are summarized in Table 4.
3. Results and discussion
Crystallization trials using the PACT-premier and JCSG-plus
screens (Molecular Dimensions) produced several hits. The
data set presented here corresponds to a P213 unit cell that is
large enough to accommodate the heterodimeric calpain I
structure when compared with the previously published
calpain II structure (Strobl et al., 2000). After initial molecular
replacement and refinement using various domains from the
previously reported -like calpain (PDB entry 1qxp (Pal et al.,
2003) and calpain II structures (PDB entry 1df0), only the
PEF(S) domain could be fitted, resulting in models with poor
Rwork and Rfree values and suggesting an incomplete solution.
Manual model building, guided only by the difference electron
density, led to a partial model for the remaining unexplained
density, which could be identified as the E. coli chaperone Hfq.
The structure determined from the highest resolution data set
is shown in Fig. 1. The impurity (Hfq) was likely to have been
overlooked in SDS gels as a small, faint band which was poorly
resolved in the 10% acrylamide gels that were used (Fig. 2). It
has been observed that the calpain I heterodimer can readily
undergo subunit dissociation under mild conditions (Pal et al.,
2001), and the stability of a PEF(S) homodimer in solution
and the tendency for the large subunit to precipitate are likely
to have contributed to the formation of the PEF(S)–Hfq
structure. Indeed, significant precipitation was observed in
many wells during the crystallization trials, including under the
conditions from which crystals were harvested.
Although Hfq is a described contaminant that has been
found to crystallize fortuitously instead of the target protein, a
complex of parts of calpain I with Hfq has not been described
previously. Hfq is part of the Sm-like family of proteins and is
a toroid-shaped, highly conserved, homohexameric protein
(Fortas et al., 2015; Brennan & Link, 2007; Schulz & Barabas,
2014). Each 8–11 kDa subunit (depending on the host
organism) comprises five coiled antiparallel -strands and an
N-terminal -helix with an unstructured C-terminus. The
expression levels of Hfq depend on the cellular growth rate
and phase, with an estimate of 5000–10 000 oligomers per cell
for log-phase E. coli in M9 medium, with 80–90% primarily
situated in the cytoplasm (Kajitani et al., 1994).
The Hfq–PEF(S) interactions show a 1:1 stoichiometry, and
are primarily hydrophilic between the fourth EF-hand in the
PEF(S) monomer and the Hfq nucleotide-binding site.
Applying crystallographic symmetry, the classic homo-
hexameric toroidal structure of Hfq can be observed and is
highly similar to the Hfq conformation observed in Hfq alone
(Schulz & Barabas, 2014; Fig. 3). The homodimeric PEF(S)
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Table 4
Structure solution and refinement.
Refinement statistics for the PEF(S)–Hfq model deposited in the PDB as
entry 6qlb.
Resolution range (A˚) 2.32
No. of reflections, working set 43741
No. of reflections, test set 2337
Final Rcryst 0.201
Final Rfree 0.247
No. of non-H atoms 7869
R.m.s. deviations
Bond lengths (A˚) 0.013
Angles () 1.855
Average B factor (A˚2) 51.2
Ramachandran plot
Most favoured (%) 97.2
Allowed (%) 2.9
Figure 1
Asymmetric unit of the calpain PEF(S)–Hfq chaperone model in cartoon
representation [PEF(S), green and red; Hfq, cyan and magenta].
Figure 2
SDS–PAGE (10%, reducing conditions) of Mono Q HR 10/10 purifica-
tion (GE Healthcare) of CAPN1C115S + CAPNS1GR, 0–0.5 M NaCl
gradient over 7 CV (lane M, molecular-weight markers labelled in kDa;
lanes A4–A17, peak fractions).
surrounds the homohexamer of Hfq. The homodimeric
PEF(S) structure is also highly analogous to previously
observed PEF(S) complexes, suggesting little disruption of
either homodimeric structure upon formation of the hetero-
dimeric complex (Adams et al., 2014). Hydrogen bonding from
the backbone O atom of Gly153 in PEF(S) to the amino group
of Gln52 in Hfq at a distance of 2.95 A˚ is observed in the
complex. The interface areas between the PEF(S) dimer pairs
(chains A–B and C–D) are 2093 and 2017 A˚2. The Hfq dimer
pairs (chains E–F and G–H) share interface areas of between
668 and 717 A˚2 (Krissinel, 2015). The mixed PEF(S)–Hfq
interface areas are smaller than each homodimer interface, at
between 444 and 506 A˚2. The interface between PEF(S) and
Hfq forms on the proximal face of the Hfq hexamer, which is
reported to be the sRNA-binding site and has been shown to
form a similar interface in an Hfq–catalase HPII complex
(Yonekura et al., 2013). Hfq has been reported to bind at least
20 proteins such as RNAse E, which are mostly involved in
genetic processes, although the functional significance of these
interactions remains unclear (Butland et al., 2005).
Additional density for a small molecule was found in a
hydrophobic pocket in the nucleotide-binding site of all Hfq
monomers, making an aromatic stacking interaction with
Tyr25 (Fig. 3). The pocket is lined with leucines and iso-
leucines, further increasing the hydrophobicity of the pocket.
The pocket is well known to accommodate nucleotides as
ligands in Hfq. The ligand was modelled as guanine, giving the
best fit to the electron density (Fig. 4). Additional density for
the ribose or phosphate groups of a nucleoside or nucleotide
could not be traced. Although guanine had not previously
been described as a ligand for this pocket, it is not
unreasonable to speculate that Hfq is rather indiscriminate
towards the base, given its function as an RNA chaperone.
We wondered whether Hfq might be involved as a
chaperone to keep PEF(S) in solution while the large subunit
PEF(L) is folded to be ready to form a complex with PEF(S).
Indeed, the strength of the interaction between PEF(S) and
PEF(L) (G = 27.2 kJ mol1) estimated using PISA (Kris-
sinel, 2010) was found to be higher than that between PEF(S)
and Hfq (G = 12.6 kJ mol1). Thus, the PEF(S)–Hfq
oligomer may be an appropriate description of how PEF(S)
is retained separately from the rest of the heterodimeric
calpain I until the counterpart PEF(L), or domain IV, is ready
to displace the chaperone and latch onto its PEF(S) and
complete the folding during expression in this E. coli strain.
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Figure 3
(a) Hfq–PEF(S) hexamer formed by crystallographic symmetry, with Hfq in cyan and magenta, and PEF(S) in green and red. (b) Hfq monomer from the
Hfq–PEF(S) complex (cyan) aligned with an Hfq monomer from the native hexamer (orange; r.m.s.d. = 0.378 A˚; Schulz & Barabas, 2014). (c) PEF(S)
monomer from the Hfq–PEF(S) complex (red) aligned with the PEF(S) monomer from the homodimeric structure (yellow; Adams et al., 2014).
Figure 4
Guanine bound in the hydrophobic pocket between Hfq (cyan) and
PEF(S) (orange). Chain residues were selected within 4 A˚ of the guanine
ligand and Ca2+ ion (green sphere), and the map is contoured at 1.0.
While this structure was not the original goal of these
crystallographic experiments, it does provide insight into the
stress that the overexpression of proteins can have on the host
bacteria, and the subsequent response to these processes. The
primary focus of studies of Hfq has been on its RNA-binding
capabilities. It has been shown to be involved in distinct
metabolic pathways, including sugar transport, membrane
remodelling and quorum sensing (Brennan & Link, 2007;
Fortas et al., 2015). Hfq protein–protein interactions have been
studied to a lesser extent, not accounting for a chaperone
function as a result of cellular stress. The structure presented
here suggests that Hfq could play a greater role in the cellular
stress response via protein-binding interactions than was
previously thought (Schulz & Barabas, 2014).
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